Enterprise Value
158M
Cash
51.18M
Avg Qtr Burn
N/A
Short % of Float
14.72%
Insider Ownership
17.28%
Institutional Own.
52.90%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PEDMARK™ (sodium thiosulfate) Details Hearing loss | Approved Quarterly sales |